Silencing microRNA by interfering nanoparticles in mice

被引:44
作者
Su, Jie [1 ]
Baigude, Huricha [1 ,2 ]
McCarroll, Joshua [1 ]
Rana, Tariq M. [1 ,2 ]
机构
[1] Univ Massachusetts, Dept Mol Pharmacol & Biochem, Sch Med, Worcester, MA 01605 USA
[2] Sanford Burnham Med Res Inst, Program RNA Biol, La Jolla, CA 92037 USA
基金
美国国家卫生研究院;
关键词
TARGET MESSENGER-RNAS; C VIRUS-INFECTION; IN-VIVO; ANIMAL DEVELOPMENT; NONHUMAN-PRIMATES; THERAPEUTIC RNAI; MODIFIED SIRNAS; REPLICATION; DISEASE; LIVER;
D O I
10.1093/nar/gkq1307
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) are small endogenous non-coding RNAs that regulate post-transcriptional gene expression and are important in many biological processes. Disease-associated miRNAs have been shown to become potential targets for therapeutic intervention. Functions of miRNAs can be inhibited by using antisense oligonucleotides, called anti-miRs, complimentary to the miRNA sequences. Here, we show that systemic delivery of a chemically stabilized anti-miR-122 complexed with interfering nanoparticles (iNOPs) effectively silences the liver-expressed miR-122 in mice. Intravenous administration of 2 mg kg(-1) chemically modified anti-miR-122 complexed with iNOP-7 resulted in 83.2 +/- 3.2% specific silencing of miR-122, which was accompanied by regulating gene expression in liver and lowering of plasma cholesterol. The specific silencing of miR-122 was long lasting and did not induce an immune response. Our results demonstrate that iNOPs can successfully deliver anti-miR to specifically target and silence miRNA in clinically acceptable and therapeutically affordable doses.
引用
收藏
页数:6
相关论文
共 40 条
[1]   MicroRNA functions in animal development and human disease [J].
Alvarez-Garcia, I ;
Miska, EA .
DEVELOPMENT, 2005, 132 (21) :4653-4662
[2]   Tolerance for mutations and chemical modifications in a siRNA [J].
Amarzguioui, M ;
Holen, T ;
Babaie, E ;
Prydz, H .
NUCLEIC ACIDS RESEARCH, 2003, 31 (02) :589-595
[3]   The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[4]   Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation [J].
Bagga, S ;
Bracht, J ;
Hunter, S ;
Massirer, K ;
Holtz, J ;
Eachus, R ;
Pasquinelli, AE .
CELL, 2005, 122 (04) :553-563
[5]   Design and creation of new nanomaterials for therapeutic RNAi [J].
Baigude, Huricha ;
McCarroll, Joshua ;
Yang, Chao-shun ;
Swain, Pamela M. ;
Rana, Tariq M. .
ACS CHEMICAL BIOLOGY, 2007, 2 (04) :237-241
[6]   Delivery of Therapeutic RNAi by Nanovehicles [J].
Baigude, Huricha ;
Rana, Tariq M. .
CHEMBIOCHEM, 2009, 10 (15) :2449-2454
[7]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[8]   bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila [J].
Brennecke, J ;
Hipfner, DR ;
Stark, A ;
Russell, RB ;
Cohen, SM .
CELL, 2003, 113 (01) :25-36
[9]   The promises and pitfalls of RNA-interference-based therapeutics [J].
Castanotto, Daniela ;
Rossi, John J. .
NATURE, 2009, 457 (7228) :426-433
[10]   Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells [J].
Chiu, YL ;
Ali, A ;
Chu, CY ;
Cao, H ;
Rana, TM .
CHEMISTRY & BIOLOGY, 2004, 11 (08) :1165-1175